Anti-SHISA6 monoclonal antibody

Pre-made anti-SHISA6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SHISA6/SHISA6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1636-Ab-1/ GM-Tg-hg-IP1636-Ab-2Anti-Human SHISA6 monoclonal antibodyHuman
GM-Tg-rg-IP1636-Ab-1/ GM-Tg-rg-IP1636-Ab-2Anti-Rat SHISA6 monoclonal antibodyRat
GM-Tg-mg-IP1636-Ab-1/ GM-Tg-mg-IP1636-Ab-2Anti-Mouse SHISA6 monoclonal antibodyMouse
GM-Tg-cynog-IP1636-Ab-1/ GM-Tg-cynog-IP1636-Ab-2Anti-Cynomolgus/ Rhesus macaque SHISA6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1636-Ab-1/ GM-Tg-felg-IP1636-Ab-2Anti-Feline SHISA6 monoclonal antibodyFeline
GM-Tg-cang-IP1636-Ab-1/ GM-Tg-cang-IP1636-Ab-2Anti-Canine SHISA6 monoclonal antibodyCanine
GM-Tg-bovg-IP1636-Ab-1/ GM-Tg-bovg-IP1636-Ab-2Anti-Bovine SHISA6 monoclonal antibodyBovine
GM-Tg-equg-IP1636-Ab-1/ GM-Tg-equg-IP1636-Ab-2Anti-Equine SHISA6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1636-Ab-1/ GM-Tg-hg-IP1636-Ab-2; GM-Tg-rg-IP1636-Ab-1/ GM-Tg-rg-IP1636-Ab-2;
GM-Tg-mg-IP1636-Ab-1/ GM-Tg-mg-IP1636-Ab-2; GM-Tg-cynog-IP1636-Ab-1/ GM-Tg-cynog-IP1636-Ab-2;
GM-Tg-felg-IP1636-Ab-1/ GM-Tg-felg-IP1636-Ab-2; GM-Tg-cang-IP1636-Ab-1/ GM-Tg-cang-IP1636-Ab-2;
GM-Tg-bovg-IP1636-Ab-1/ GM-Tg-bovg-IP1636-Ab-2; GM-Tg-equg-IP1636-Ab-1/ GM-Tg-equg-IP1636-Ab-2
Products NameAnti-SHISA6 monoclonal antibody
Formatmab
Target NameSHISA6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SHISA6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1636-Ag-1Recombinant multi-species SHSA6/ SHISA6 protein


    Target information

    Target IDGM-IP1636
    Target NameSHISA6
    Gene ID388336,380702,497926,722098,489506,101085932,539499,100073090
    Gene Symbol and Synonymsckamp52,Gm879,RGD1564618,SHISA6
    Uniprot AccessionQ6ZSJ9
    Uniprot Entry NameSHSA6_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188803
    Target ClassificationN/A

    The target: SHISA6, gene name: SHISA6, also named as . Predicted to enable ionotropic glutamate receptor binding activity. Predicted to be involved in several processes, including excitatory chemical synaptic transmission; regulation of short-term neuronal synaptic plasticity; and regulation of signal transduction. Predicted to be located in asymmetric, glutamatergic, excitatory synapse. Predicted to be part of AMPA glutamate receptor complex. Predicted to be active in glutamatergic synapse; postsynaptic density; and synaptic membrane. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.